Pfizer tops Q3 forecasts as total COVID vaccine sales soar

almost 4 years in My VUE news

By TOM MURPHY Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S. Soaring internationalRead More...

Mentioned in this news
Share it on